Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64Cu-labeled TRC105.
暂无分享,去创建一个
J. Zagzebski | Yin Zhang | H. Hong | W. Cai | T. Barnhart | H. Orbay | C. Theuer | T. Hacker | H. Valdovinos | Hakan Orbay
[1] F. Jaffer,et al. Intravascular near-infrared fluorescence molecular imaging of atherosclerosis. , 2013, American journal of nuclear medicine and molecular imaging.
[2] Yin Zhang,et al. Positron emission tomography imaging of tumor angiogenesis with a (61/64)Cu-labeled F(ab')(2) antibody fragment. , 2013, Molecular pharmaceutics.
[3] Hao Hong,et al. PET imaging of CD105/endoglin expression with a 61/64Cu-labeled Fab antibody fragment , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[4] Yin Zhang,et al. PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow , 2012, Angiogenesis.
[5] K. Sunagawa,et al. Nanoparticle-Mediated Delivery of Pioglitazone Enhances Therapeutic Neovascularization in a Murine Model of Hindlimb Ischemia , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[6] Yin Zhang,et al. Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW. , 2012, Molecular pharmaceutics.
[7] Donald D. Nolting,et al. Molecular imaging probe development: a chemistry perspective. , 2012, American journal of nuclear medicine and molecular imaging.
[8] David S Mendelson,et al. A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer , 2012, Clinical Cancer Research.
[9] Yin Zhang,et al. Positron emission tomography imaging of tumor angiogenesis with a 66Ga-labeled monoclonal antibody. , 2012, Molecular pharmaceutics.
[10] Sanjiv S Gambhir,et al. A molecular imaging primer: modalities, imaging agents, and applications. , 2012, Physiological reviews.
[11] Yin Zhang,et al. Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody. , 2012, Molecular pharmaceutics.
[12] Yasser Khalil,et al. The Relationship of Peripheral Arterial Disease and Metabolic Syndrome Prevalence in Asymptomatic US Adults 40 Years and Older: Results From the National Health and Nutrition Examination Survey (1999–2004) , 2012, Journal of clinical hypertension.
[13] J. Weber,et al. Current State of Diagnosis and Management of Critical Limb Ischemia , 2012, Current Cardiology Reports.
[14] J. Reekers,et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease , 2012, Diabetes/metabolism research and reviews.
[15] Yin Zhang,et al. Positron Emission Tomography Imaging of CD105 Expression with a 64Cu-Labeled Monoclonal Antibody: NOTA Is Superior to DOTA , 2011, PloS one.
[16] Eric D. Pressly,et al. Targeting Angiogenesis Using a C-Type Atrial Natriuretic Factor–Conjugated Nanoprobe and PET , 2011, The Journal of Nuclear Medicine.
[17] R. Domingues,et al. PET/CT and vascular disease: current concepts. , 2011, European journal of radiology.
[18] Yin Zhang,et al. Positron emission tomography imaging of CD105 expression during tumor angiogenesis , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[19] D. Mooney,et al. Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis. , 2011, Nano letters.
[20] C. Anderson,et al. Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. , 2010, Chemical reviews.
[21] Monica Shokeen,et al. Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis , 2009, Proceedings of the National Academy of Sciences.
[22] P. Quax,et al. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. , 2008, Annals of vascular surgery.
[23] Weibo Cai,et al. Multimodality Molecular Imaging of Tumor Angiogenesis , 2008, Journal of Nuclear Medicine.
[24] Young Joo Kim,et al. Preparation of a Promising Angiogenesis PET Imaging Agent: 68Ga-Labeled c(RGDyK)–Isothiocyanatobenzyl-1,4,7-Triazacyclononane-1,4,7-Triacetic Acid and Feasibility Studies in Mice , 2008, Journal of Nuclear Medicine.
[25] L. Ellis,et al. Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy , 2008, Clinical Cancer Research.
[26] J. Willmann,et al. Monitoring of the Biological Response to Murine Hindlimb Ischemia With 64Cu-Labeled Vascular Endothelial Growth Factor-121 Positron Emission Tomography , 2008, Circulation.
[27] F. Prósper,et al. 13N-Ammonia PET as a Measurement of Hindlimb Perfusion in a Mouse Model of Peripheral Artery Occlusive Disease , 2007, Journal of Nuclear Medicine.
[28] Sanjiv S. Gambhir,et al. How molecular imaging is speeding up antiangiogenic drug development , 2006, Molecular Cancer Therapeutics.
[29] J. Pearlman,et al. Impact of Mouse Strain Differences in Innate Hindlimb Collateral Vasculature , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[30] J. Dunn,et al. Delayed Arteriogenesis in Hypercholesterolemic Mice , 2005, Circulation.
[31] B. Seon,et al. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide. , 2001, Cancer research.
[32] M. Maio,et al. Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[33] J. Isner,et al. Mouse model of angiogenesis. , 1998, The American journal of pathology.
[34] P. Sharp,et al. Measurement of Lower Limb Blood Flow in Patients With Neurogenic Claudication Using Positron Emission Tomography , 1995, Spine.
[35] G. Del Fiore,et al. Effect of exercise on the leg distribution of C15O2 and 15O2 in normals and in patients with peripheral ischemia: a study using positron tomography. , 1988, International angiology : a journal of the International Union of Angiology.
[36] J. Seo,et al. A comparison of image contrast with (64)Cu-labeled long circulating liposomes and (18)F-FDG in a murine model of mammary carcinoma. , 2013, American journal of nuclear medicine and molecular imaging.
[37] H. Saji,et al. Radiolabelled probes for imaging of atherosclerotic plaques. , 2012, American journal of nuclear medicine and molecular imaging.
[38] Yin Zhang,et al. Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab. , 2012, American journal of nuclear medicine and molecular imaging.
[39] Georges El Fakhri,et al. Ready for prime time? Dual tracer PET and SPECT imaging. , 2012, American journal of nuclear medicine and molecular imaging.
[40] Yin Zhang,et al. ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with (89)Zr and IRDye 800CW. , 2012, American journal of translational research.
[41] M. Alauddin,et al. Positron emission tomography (PET) imaging with (18)F-based radiotracers. , 2012, American journal of nuclear medicine and molecular imaging.
[42] Yin Zhang,et al. Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105 , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[43] Albert J. Sinusas,et al. PET and SPECT in cardiovascular molecular imaging , 2010, Nature Reviews Cardiology.